Conflict of Interest and T 2 Diabetes therapy: AACE and ADA/EASD' Current Glycemia Guidelines

Prevention of microvascular and macrovascular complications rests on timely institution of drug therapy by the prescribing physician, usually a general practitioner (GP), and the patient's compliance with the treatment regimen and willingness to make lifestyle changes.
Optimal use of clinical practice guidelines (CPGs) in general practice demands specific implementation strategies aiming at the reduction of barriers to high-quality care. Clinical practice guidelines are potentially useful for health services and health workforce planning, but would be more valuable for this aim if they contained more detail about care protocols and specific skills and competencies especially for general practitioners who would be expected to have reduced capacity for effective high-quality care.Subsequently, many patients will not receive such level of care despite the availability of international treatment guidelines describing the supposed optimal management of patients with diabetes. Hence, a clear understanding on how to overcome this knowledge-action gap in diabetes seems to be lacking, despite previous studies which outlined the obstacles that prevent GPs from following the CPGs. So the only winner in such battle field is the pharmaceutical companies. Because we as healthcare professionals control the market for products that we neither pay for nor consume, and whose unwanted consequences are experienced by patients.

• Category

  • Howto & Style

• License

  • Standard YouTube License